| Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging AJ Grippin, B Wummer, T Wildes, K Dyson, V Trivedi, C Yang, ... ACS nano 13 (12), 13884-13898, 2019 | 70 | 2019 |
| Personalized tumor RNA loaded lipid-nanoparticles prime the systemic and intratumoral milieu for response to cancer immunotherapy EJ Sayour, A Grippin, G De Leon, B Stover, M Rahman, A Karachi, ... Nano letters 18 (10), 6195-6206, 2018 | 65 | 2018 |
| Cross-talk between T cells and hematopoietic stem cells during adoptive cellular therapy for malignant glioma TJ Wildes, A Grippin, KA Dyson, BM Wummer, DJ Damiani, RS Abraham, ... Clinical Cancer Research 24 (16), 3955-3966, 2018 | 36 | 2018 |
| Immune escape after adoptive T-cell therapy for malignant gliomas TJ Wildes, KA Dyson, C Francis, B Wummer, C Yang, O Yegorov, D Shin, ... Clinical Cancer Research 26 (21), 5689-5700, 2020 | 29 | 2020 |
| Brain stem gliomas and current landscape B Wummer, D Woodworth, C Flores Journal of Neuro-Oncology 151, 21-28, 2021 | 6 | 2021 |
| Nanoparticles as immunomodulators and translational agents in brain tumors AJ Grippin, KA Dyson, S Qdaisat, J McGuiness, B Wummer, DA Mitchell, ... Journal of Neuro-Oncology 151, 29-39, 2021 | 5 | 2021 |
| Implementation of an opioid reduction toolkit in pancreatectomy patients significantly increases patient awareness of safe practice and decreases amount prescribed and consumed R Lamm, S Cannaday, F Ponzini, D Moskal, M Lundgren, JE Williamson, ... HPB 25 (7), 807-812, 2023 | 2 | 2023 |
| IMMUNOTHERAPY REVERSES GLIOMA-DRIVEN DYSFUNCTION OF IMMUNE SYSTEM HOMEOSTASIS B Dean, T Wildes, J Dean, D Shin, C Francis, M Sebastian, LF Font, ... NEURO-ONCOLOGY 24, 225-225, 2022 | 2 | 2022 |
| Versatile mRNA-nanoparticle platform for treatment of glioblastoma A Grippin, B Wummer, T Wildes, K Dyson, H Mendez-Gomez, J Dobson, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), e251-e252, 2021 | 2 | 2021 |
| Immu-41. Versatile mRNA-Nanoparticle Platform to Reprogram the Brain Tumor Microenvironment and Predict Treatment Outcome A Grippin, H Mendez-Gomez, B Wummer, F Weidert, T Wildes, K Dyson, ... Neuro-Oncology 24 (Suppl 7), vii140, 2022 | 1 | 2022 |
| mRNA-nanoparticles to enhance and track dendritic cell migration. A Grippin, E Sayour, B Wummer, A Monsalve, T Wildes, K Dyson, ... Journal of Clinical Oncology 36 (5_suppl), 72-72, 2018 | 1 | 2018 |
| Materials and methods for sensitizing tumors to immune response E Sayour, HR Mendez-gomez, S Qdaisat, B Wummer, DA Mitchell US Patent App. 18/037,516, 2023 | | 2023 |
| DEVELOPMENTALLY REGULATED ANTIGENS FOR IMMUNOLOGIC TARGETING OF EMBRYONAL PEDIATRIC BRAIN CANCERS M Sebastian, C Pham, B Wummer, D Woodworth, A Reid, R Abraham, ... NEURO-ONCOLOGY 24, 228-228, 2022 | | 2022 |
| Opioid reduction in pancreatectomy patients: driving down dependence and depleting the diversion pool R Lamm, S Cannaday, F Ponzini, D Moskal, JE Williamson III, B Wummer, ... | | 2022 |
| High grade gliomas impact cell fate differentiation of hematopoietic stem and progenitor cells in the bone marrow BDV Dean, T Wildes, J Dean, D Shin, C Francis, LF Font, G Moore, ... The Journal of Immunology 206 (1_Supplement), 58.10-58.10, 2021 | | 2021 |
| In Vitro Anti-programmed Cell Death 1 Therapy Rescues Tumor Infiltrating Lymphocyte Exhaustion in a Murine Glioma Model D Shin, B Wummer, B Dean, F Connor, G Moore, C Flores, D Mitchell Neurosurgery 67, 2020 | | 2020 |
| IMMU-45. CUSTOMIZED LIPID NANOPARTICLES DELIVER NUCLEIC ACIDS TO IMMUNE CELLS IN BRAIN TUMORS A Grippin, B Wummer, H Mendez-Gomez, T Wildes, K Dyson, J Dobson, ... Neuro-Oncology 22 (Suppl 2), ii114, 2020 | | 2020 |
| IMMU-22. EARLY RELEASE OF TYPE I INTERFERON DRIVES BRAIN CANCER IMMUNOGENICITY AND RESPONSE TO IMMUNOTHERAPY B Wummer, S Qdaisat, A Grippin, A Karachi, F Weidert, J Huang, ... Neuro-Oncology 22 (Supplement_2), ii109-ii109, 2020 | | 2020 |
| IMMU-13. MECHANISMS OF IMMUNOLOGICAL ESCAPE DURING ADOPTIVE CELLULAR THERAPY IN HIGH GRADE GLIOMA T Wildes, K Dyson, C Francis, B Wummer, C Yang, O Yegorov, D Shin, ... Neuro-Oncology 21 (Suppl 6), vi121, 2019 | | 2019 |
| IMMU-32. RNA-NANOPARTICLE VACCINES MEDIATE T CELL TRAFFICKING NECESSARY FOR BBB PASSAGE AND ANTI-GLIOMA IMMUNE RESPONSE H Mendez-Gomez, B Wummer, A Grippin, F Weidert, J Huang, ... Neuro-Oncology 21 (Suppl 6), vi125, 2019 | | 2019 |
